Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009405 · ClinicalTrials.gov registry record · NA
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
A NA study of IV Infiltration and IV Extravasation, sponsored by Rhaeos.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07009405 is a NA study of IV Infiltration and IV Extravasation that is actively recruiting participants, run by Rhaeos. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07009405, a NA study of IV Infiltration and IV Extravasation, is actively recruiting participants, sponsored by Rhaeos.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
Conditions Studied
Interventions
- DEVICE non-invasive thermal infusion site monitoring NTISM device
Study Locations (1)
Illinois
- Infusacare - Skokie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07009405
The ClinicalTrials.gov registry entry for NCT07009405 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with IV Infiltration appearing as the primary indexed condition, and to 1 intervention - of which non-invasive thermal infusion site monitoring NTISM device is the first listed.
NCT07009405 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07009405 about?
NCT07009405 is a clinical study titled "Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During". This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
What is the current status of trial NCT07009405?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-28. Estimated completion is 2025-12.
What conditions does trial NCT07009405 study?
This clinical trial studies the following conditions: IV Infiltration, IV Extravasation.
What interventions are being tested in trial NCT07009405?
The interventions under investigation include: non-invasive thermal infusion site monitoring NTISM device (DEVICE).
Who is sponsoring clinical trial NCT07009405?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009405 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IV Infiltration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.